Abstract Prostaglandin E receptor 3 (PTGER3) is involved in a variety of biological
processes in the human body and is closely associated with the development and …

Effective targeted therapeutic strategies for triple-negative breast cancer (TNBC), the most
malignant subtype of breast cancer, are currently lacking. Ferroptosis has been reported to …

Objective Triple-negative breast cancer (TNBC) is the most malignant form of breast cancer
with increasing incidence and mortality worldwide. The progesterone receptor membrane …

Background: Triple-negative breast cancer (TNBC) is a subtype of BC with high rates of
mortality. The mechanism of PTPRG-AS1 in ferroptosis of TNBC was investigated. Methods …

Background TNBC is the most aggressive breast cancer with higher recurrence and
mortality rate than other types of breast cancer. There is an urgent need for identification of …

Purpose Triple negative breast cancer (TNBC) is a challenging subtype characterized by the
absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal …

The TP53 tumor suppressor gene is mutated early in most of the patients with triple-negative
breast cancer (TNBC). The most frequent TP53 alterations are missense mutations that …

Treatment of triple-negative breast cancer (TNBC) remains challenging. Deciphering the
orchestration of metabolic pathways in regulating ferroptosis will provide new insights into …

Gefitinib resistance in triple negative breast cancer (TNBC) is a growing important concern.
Glutathione peroxidase 4 (GPX4) is a main regulator of ferroptosis, which is pivotal for TNBC …

Triple-negative breast cancer (TNBC) is a highly heterogeneous breast tumor type that is
highly malignant, invasive, and highly recurrent. Ferroptosis is a unique mode of …